Tobacco Giant Philip Morris To Offload Vectura After Controversy Scuppered Relationships
UK-Based Inhalation Specialist Thwarted In ‘Scientific Engagement,’ CDMO Dealings
Philip Morris described a scenario of being essentially blacklisted by the healthcare sector and its CDMO partners, as the tobacco manufacturer threw in the towel on its £1.1bn acquisition of UK-based inhalation specialist Vectura by agreeing to offload the firm at a fraction of the initial cost.
